O36.113
Maternal care for Anti-A sensitization, third trimester
Clinical Classification Guidelines
Medical Intelligence & Overview
Anti-A sensitization refers to a condition where a pregnant woman's immune system develops antibodies against the A blood group antigen. This can pose risks to the developing fetus, particularly in cases of Rh incompatibility. Managing this sensitization during the third trimester is critical to prevent complications such as hemolytic disease of the fetus and newborn (HDFN). Proper maternal care involves monitoring, testing, and interventions to ensure the health of both mother and baby throughout the pregnancy.
Causes & Symptoms
Clinical Causes: Previous exposure to A antigen through transfusion or pregnancy Pregnancy with an fetus carrying the A blood group antigen Unrecognized blood type incompatibilities Inadequate screening for blood group antibodies during early pregnancy Absence of prophylactic treatment, such as Rh immunoglobulin in at-risk pregnancies
Key Symptoms: Typically asymptomatic in the mother Signs of fetal anemia in severe cases, including fatigue or poor fetal movement Signs of fetal hydrops in advanced cases, such as swelling, skin thickening, or fluid accumulation Possible jaundice or anemia in the newborn after delivery
Diagnostic & Treatment
Diagnosis Path: Blood tests to determine maternal blood type and antibody presence Antibody screen and titers to assess the level of sensitization Amniocentesis or ultrasound to evaluate fetal well-being and possible anemia Doppler ultrasound to measure fetal blood flow and identify signs of anemia Post-delivery tests to assess newborn's hemolytic status
Treatment Protocols: Close monitoring of maternal antibody levels and fetal health throughout the third trimester Intrauterine transfusions if fetal anemia becomes severe Preparation for potential neonatal care, including phototherapy or exchange transfusion after birth Postnatal assessment of the newborn for signs of hemolysis or anemia Preventive measures in future pregnancies, such as Rh immunoglobulin administration if applicable
Clinical Advice & FAQs
Billing Guidance
Is O36.113 a billable ICD-10 code?
Yes, O36.113 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O36.113?
Clinical documentation must specify the nature of Maternal care for Anti-A sensitization, third trimester and any associated comorbidities for accurate reporting.
Cite this Clinical Reference